tradingkey.logo


tradingkey.logo


Dr Reddy's Laboratories Ltd

RDY
14.200USD
+0.260+1.87%
終倀 12/19, 16:00ET15分遅れの株䟡
11.82B時䟡総額
17.32盎近12ヶ月PER


Dr Reddy's Laboratories Ltd

14.200
+0.260+1.87%

詳现情報 Dr Reddy's Laboratories Ltd 䌁業名

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Dr Reddy's Laboratories Ltdの䌁業情報


䌁業コヌドRDY
䌚瀟名Dr Reddy's Laboratories Ltd
䞊堎日Jan 01, 1986
最高経営責任者「CEO」Aghanian (Patrick)
埓業員数27811
蚌刞皮類Depository Receipt
決算期末Jan 01
本瀟所圚地8-2-337, Road No.3 Banjara Hills
郜垂HYDERABAD
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜India
郵䟿番号500-034
電話番号914049002900
りェブサむトhttps://www.drreddys.com/
䌁業コヌドRDY
䞊堎日Jan 01, 1986
最高経営責任者「CEO」Aghanian (Patrick)

Dr Reddy's Laboratories Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Sanjiv Soshil Mehta
Mr. Sanjiv Soshil Mehta
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phanimitra (Phani) B
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
Chief Digital and Information Officer
--
--
Mr. Mannam Venkata Narasimham
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Richa Periwal
Ms. Richa Periwal
Investor Relations
Investor Relations
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. K. Randhir Singh
Mr. K. Randhir Singh
Compliance Officer, Company Secretary, Head - CSR
Compliance Officer, Company Secretary, Head - CSR
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Chan (Penny) Wan
Ms. Chan (Penny) Wan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Arun Madhavan Kumar
Mr. Arun Madhavan Kumar
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Sanjiv Soshil Mehta
Mr. Sanjiv Soshil Mehta
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phanimitra (Phani) B
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
Chief Digital and Information Officer
--
--
Mr. Mannam Venkata Narasimham
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Richa Periwal
Ms. Richa Periwal
Investor Relations
Investor Relations
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
427.18M
42.77%
Other
309.06M
30.94%
India
179.87M
18.01%
Russia
82.79M
8.29%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Dec 11
曎新時刻: Thu, Dec 11
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Robeco Institutional Asset Management B.V.
1.57%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.81%
他の
94.20%
株䞻統蚈
株䞻統蚈
比率
Robeco Institutional Asset Management B.V.
1.57%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.81%
他の
94.20%
皮類
株䞻統蚈
比率
Investment Advisor
6.56%
Investment Advisor/Hedge Fund
4.39%
Hedge Fund
1.20%
Research Firm
1.12%
Pension Fund
0.33%
Family Office
0.19%
Family Office
0.10%
Family Office
0.10%
Bank and Trust
0.08%
他の
85.93%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
516
112.51M
13.51%
-15.88M
2025Q2
504
118.15M
14.19%
-12.22M
2025Q1
506
114.84M
13.80%
-17.55M
2024Q4
478
124.61M
14.96%
-2.62M
2024Q3
462
118.95M
14.28%
-16.57M
2024Q2
445
126.18M
15.15%
-4.51M
2024Q1
437
124.83M
14.99%
-5.58M
2023Q4
427
125.49M
15.07%
-4.37M
2023Q3
406
119.09M
14.31%
-4.07M
2023Q2
397
109.36M
13.16%
-3.97M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Robeco Institutional Asset Management B.V.
12.16M
1.46%
+1.45M
+13.56%
Jun 30, 2025
Aperio Group, LLC
9.26M
1.11%
+2.30M
+33.13%
Jun 30, 2025
RBC Global Asset Management (UK) Limited
9.33M
1.12%
+281.97K
+3.12%
Jun 30, 2025
Renaissance Technologies LLC
9.01M
1.08%
-182.10K
-1.98%
Jun 30, 2025
Aikya Investment Management Limited
6.35M
0.76%
+154.60K
+2.49%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
5.40M
0.65%
-64.08K
-1.17%
Jun 30, 2025
The Vanguard Group, Inc.
4.98M
0.6%
-27.59K
-0.55%
Jun 30, 2025
Parametric Portfolio Associates LLC
4.28M
0.51%
+631.20K
+17.32%
Jun 30, 2025
State Street Investment Management (US)
4.19M
0.5%
+131.99K
+3.25%
Jun 30, 2025
BNP Paribas Securities Corp. North America
4.01M
0.48%
-569.44K
-12.42%
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
National Security Emerging Markets Index ETF
0.91%
Invesco S&P Emerging Markets Low Volatility ETF
0.39%
Lattice Hartford Multifactor Emerging Markets ETF
0.33%
DFA Dimensional Emerging Markets Value ETF
0.22%
ActivePassive International Equity ETF
0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
0.13%
SPDR Portfolio Emerging Markets ETF
0.12%
Avantis Emerging Markets Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.12%
詳现を芋る
National Security Emerging Markets Index ETF
比率0.91%
Invesco S&P Emerging Markets Low Volatility ETF
比率0.39%
Lattice Hartford Multifactor Emerging Markets ETF
比率0.33%
DFA Dimensional Emerging Markets Value ETF
比率0.22%
ActivePassive International Equity ETF
比率0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
比率0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
比率0.13%
SPDR Portfolio Emerging Markets ETF
比率0.12%
Avantis Emerging Markets Equity ETF
比率0.12%
SP Funds S&P World (ex-US) ETF
比率0.12%

配圓金


過去5幎間の配圓金総支払額は 332.70M 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
May 09, 2024
RDY.NB Final Cash Dividend of gross USD 0.476153 paid on Aug 12, 2024 going ex on Jul 30, 2024
Jul 15, 2024
Aug 12, 2024
Jul 30, 2024
May 11, 2023
RDY.NB Final Cash Dividend of gross USD 0.482608 paid on Aug 11, 2023 going ex on Jul 28, 2023
Jul 10, 2023
Aug 11, 2023
Jul 28, 2023
May 24, 2022
RDY.NB Final Cash Dividend of gross USD 0.378434 paid on Aug 12, 2022 going ex on Aug 01, 2022
Jul 11, 2022
Aug 12, 2022
Aug 01, 2022
Jun 16, 2021
RDY.NB Final Cash Dividend of gross USD 0.336485 paid on Aug 11, 2021 going ex on Jul 30, 2021
Jul 09, 2021
Aug 11, 2021
Jul 30, 2021
Jun 26, 2020
RDY.NB Final Cash Dividend of gross USD 0.333364 paid on Aug 17, 2020 going ex on Jul 10, 2020
Jul 13, 2020
Aug 17, 2020
Jul 10, 2020

株匏分割


日付
皮類
比率
Oct 07, 2024
Split
1→5
日付
皮類
比率
Oct 07, 2024
Split
1→5

よくある質問

Dr Reddy's Laboratories Ltdの䞊䜍5名の株䞻は誰ですか


Dr Reddy's Laboratories Ltdの䞊䜍5名の株䞻は以䞋のずおりです。
Robeco Institutional Asset Management B.V.は12.16M株を保有しおおり、これは党䜓の1.46%に盞圓したす。
Aperio Group, LLCは9.26M株を保有しおおり、これは党䜓の1.11%に盞圓したす。
RBC Global Asset Management (UK) Limitedは9.33M株を保有しおおり、これは党䜓の1.12%に盞圓したす。
Renaissance Technologies LLCは9.01M株を保有しおおり、これは党䜓の1.08%に盞圓したす。
Aikya Investment Management Limitedは6.35M株を保有しおおり、これは党䜓の0.76%に盞圓したす。

Dr Reddy's Laboratories Ltdの株䞻タむプ䞊䜍3皮は䜕ですか


Dr Reddy's Laboratories Ltdの株䞻タむプ䞊䜍3皮は、
Robeco Institutional Asset Management B.V.
Aperio Group, LLC
RBC Global Asset Management (UK) Limited

Dr Reddy's Laboratories LtdRDYの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Dr Reddy's Laboratories Ltdの株匏を保有しおいる機関は516瀟あり、保有株匏の総垂堎䟡倀は玄112.51Mで、党䜓の13.51%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-0.68%増加しおいたす。

Dr Reddy's Laboratories Ltdの最倧の収益源は䜕ですか


FY2026Q1においお、--郚門がDr Reddy's Laboratories Ltdにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™